Development of Noncytotoxic PLGA Nanoparticles to Improve the Effect of a New Inhibitor of P53–MDM2 Interaction

International Journal of Pharmaceutics - Netherlands
doi 10.1016/j.ijpharm.2013.07.017
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

P53 Mediated Death of Cells Overexpressing MDM2 by an Inhibitor of MDM2 Interaction With P53

Oncogene
Cancer ResearchGeneticsMolecular Biology
1999English

Targeting Neuroblastoma With a New Inhibitor of the TAp73 Interaction With MDM2 and Mutant P53

2019English

Discovery of SCY45, a Natural Small‐Molecule MDM2‐p53 Interaction Inhibitor.

Chemistry and Biodiversity
Molecular MedicineMolecular BiologyBiochemistryMedicineBioengineeringChemistry
2019English

The Interaction Between P53 and Mdm2 Is Independent of MEG3–p53 Association

2019English

The Isolation, Total Synthesis and Structure Elucidation of Chlorofusin, a Natural Product Inhibitor of the P53–MDM2 Protein–protein Interaction

Natural Product Reports
BiochemistryOrganic ChemistryDrug Discovery
2009English

A Dimethylbromobenzene-Cysteine Stapled Peptide Dual Inhibitor of the P53-Mdm2/MDMX Interactions

Hepatoma Research
2019English

Discovery of Potent and Simplified Piperidinone-Based Inhibitors of the MDM2–p53 Interaction

ACS Medicinal Chemistry Letters
Organic ChemistryBiochemistryDrug Discovery
2014English

Evolution of the P53-Mdm2 Pathway

BMC Evolutionary Biology
EvolutionEcologySystematicsBehavior
2017English

Searching for Dual Inhibitors of the MDM2-p53 and MDMX-p53 Protein-Protein Interaction by a Scaffold-Hopping Approach

Chemical Biology and Drug Design
BiochemistryOrganic ChemistryDrug DiscoveryMolecular MedicinePharmacology
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy